SPIMACO (2070.SR)

Executive Summary

SPIMACO is Saudi Arabia's leading private pharmaceutical manufacturer, commanding the #1 market position with a diversified portfolio of over 400 products across multiple therapeutic categories. The company operates seven state-of-the-art facilities across four countries, producing over 2.3 billion units annually and serving 21 strategic markets in the Middle East and North Africa. With a strong commitment to quality and GMP compliance, SPIMACO has established itself as a trusted partner in the regional pharmaceutical supply chain. The company is publicly listed on the Saudi Stock Exchange with a market capitalization of approximately $3.5 billion, reflecting its dominant market position and growth potential.

Upcoming Catalysts (preview)

• Q3 2026New market entry in Africa via distribution agreements80% success
• Q4 2026Launch of a high-value biosimilar product60% success
• Q3 2026Government partnership under Saudi Vision 2030 for local manufacturing expansion70% success